These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33543161)

  • 1. Editorial: The ongoing challenge of diagnosing endocrine diseases.
    Woods A
    Aust J Gen Pract; 2021; 50(1-2):5. PubMed ID: 33543161
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic complications of nondiabetic endocrine disorders.
    Ishii M
    Continuum (Minneap Minn); 2014 Jun; 20(3 Neurology of Systemic Disease):560-79. PubMed ID: 24893234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial overview: Endocrine and metabolic diseases: conversations on endocrine disruptors - rising above the din.
    Belcher SM
    Curr Opin Pharmacol; 2014 Dec; 19():vi-vii. PubMed ID: 25444363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endocrine diseases: progress in diagnosis and treatments. Editorial: update on diagnostic and treatment strategies in endocrine diseases].
    Oiso Y
    Nihon Naika Gakkai Zasshi; 2014 Apr; 103(4):823-4. PubMed ID: 24908977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endocrine disease: progress in diagnosis and treatment. Editorial: endocrine disease, diagnosis and treatment].
    Hirata Y
    Nihon Naika Gakkai Zasshi; 2012 Apr; 101(4):911-2. PubMed ID: 22730716
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Toxicol In Vitro; 2020 Sep; 67():104862. PubMed ID: 32360642
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endocrine and Metabolic Emergencies; Points of Initial Management. Editorial: Endocrine and metabolic emergencies].
    Itoh H; Yokota K
    Nihon Naika Gakkai Zasshi; 2016 Apr; 105(4):637-9. PubMed ID: 27491255
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial commentary: Treatment of refractory angina: An ongoing challenge.
    Thadani U
    Trends Cardiovasc Med; 2018 Apr; 28(3):229-230. PubMed ID: 29273184
    [No Abstract]   [Full Text] [Related]  

  • 9. Radionuclides in endocrine imaging.
    Sandler MP; Delbeke D
    Radiol Clin North Am; 1993 Jul; 31(4):909-21. PubMed ID: 8337374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Cell Signaling in Tumors of Endocrine and Endocrine-Responsive Tissues.
    Perks C; Hague A
    Front Endocrinol (Lausanne); 2019; 10():211. PubMed ID: 31024450
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
    Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Algorithms for diagnosing the most frequent endocrine diseases in clinical practice].
    Kalvachová B
    Cesk Pediatr; 1991 Jan; 46(1):46-7. PubMed ID: 1884416
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing common endocrine disorders amid COVID-19 pandemic.
    Pal R; Bhadada SK
    Diabetes Metab Syndr; 2020; 14(5):767-771. PubMed ID: 32521463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: The "oat-cell" tumors: a medical and biological challenge.
    Barden RP
    Radiology; 1974 Sep; 112(3):743-4. PubMed ID: 4367252
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in endocrine metabolic immune disorders drug targeting: an editorial overview.
    Magrone T; Jirillo E
    Endocr Metab Immune Disord Drug Targets; 2015; 15(1):1-8. PubMed ID: 25800124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Endocrine Disrupters and Metabolism.
    Gibert Y; Sargis RM; Nadal A
    Front Endocrinol (Lausanne); 2019; 10():859. PubMed ID: 31920972
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Endocrine tumors, rare tumors.
    Jungels C
    Curr Opin Oncol; 2021 Jan; 33(1):1-2. PubMed ID: 33273300
    [No Abstract]   [Full Text] [Related]  

  • 18. Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.
    Schettini F; Santo I; Rea CG; Viggiani M; Buono G; Angelis C; Cardalesi C; Lauria R; Giuliano M; Forestieri V; Thomas G; Maione P; Limite G; Accurso A; Malorni L; Placido S; Arpino G
    Mol Clin Oncol; 2020 May; 12(5):456-460. PubMed ID: 32257203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late endocrine effects in pediatric central nervous system diseases.
    Aslan IR; Cheung CC
    J Pediatr Rehabil Med; 2014; 7(4):281-94. PubMed ID: 25547881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Autophagy in Endocrine-Metabolic Diseases Associated With Aging.
    Vaccaro MI; De Tata V; Gonzalez CD
    Front Endocrinol (Lausanne); 2020; 11():572. PubMed ID: 32973685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.